Bett JS, Goellner GM, Woodman B, Pratt G, Rechsteiner M, Bates GP.
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.Hum Mol Genet.
2006 Jan 1;15(1):33-44.
PubMed Abstract